We are live on ! Find out more
AWCI

Alpine Woods Capital Investors Portfolio holdings

AUM $460M
1-Year Est. Return 30.5%
This Fund
S&P 500
This Quarter Est. Return
-3.83%
1 Year Est. Return
+30.5%
3 Year Est. Return
+104.98%
5 Year Est. Return
+116.86%
10 Year Est. Return
+408.45%
AUM
$950M
AUM Growth
-$62.7M
Cap. Flow
-$9.93M
Cap. Flow %
-1.05%
Top 10 Hldgs %
21.68%
Holding
228
New
18
Increased
38
Reduced
95
Closed
16

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$9.94M
2
DGX icon
Quest Diagnostics
DGX
+$9.2M
3
CMI icon
Cummins
CMI
+$8.79M
4
JPM icon
JPMorgan Chase
JPM
+$7.61M
5
MSFT icon
Microsoft
MSFT
+$7.47M

Sector Composition

Rank Sector Weight
1 Technology 23.77%
2 Healthcare 13.32%
3 Financials 13.15%
4 Industrials 13.14%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
26
Thermo Fisher Scientific
TMO
$223B
$9.7M 1.02%
16,427
-150
-0.9% -$86.2K
GRMN
27
Garmin
GRMN
$59.8B
$9.61M 1.01%
80,999
+39,033
+93% +$4.7M
DLR icon
28
Digital Realty Trust
DLR
$72.9B
$9.59M 1.01%
67,600
-1,831
-3% -$265K
ABBV icon
29
AbbVie
ABBV
$440B
$9.56M 1.01%
58,983
-9,470
-14% -$1.38M
AKAM icon
30
Akamai
AKAM
$17.6B
$9.54M 1%
79,876
-1,434
-2% -$161K
ADBE icon
31
Adobe
ADBE
$103B
$9.41M 0.99%
+20,658
New +$9.94M
AMD icon
32
Advanced Micro Devices
AMD
$788B
$9.25M 0.97%
84,588
+17,038
+25% +$2.03M
CME icon
33
CME Group
CME
$94.3B
$9.19M 0.97%
38,653
-20,140
-34% -$4.73M
INGR icon
34
Ingredion
INGR
$6.54B
$9.07M 0.95%
104,082
-1,264
-1% -$114K
ZBRA icon
35
Zebra Technologies
ZBRA
$17.9B
$9.07M 0.95%
21,926
-106
-0.5% -$48.7K
MET icon
36
MetLife
MET
$61.4B
$8.78M 0.92%
124,971
+41,440
+50% +$2.8M
QCOM icon
37
Qualcomm
QCOM
$171B
$8.65M 0.91%
56,624
-2,406
-4% -$404K
POR icon
38
Portland General Electric
POR
$5.74B
$8.62M 0.91%
156,253
-7,502
-5% -$395K
RTX icon
39
RTX Corp
RTX
$300B
$8.58M 0.9%
86,632
-6,557
-7% -$621K
CMI icon
40
Cummins
CMI
$87.8B
$8.34M 0.88%
+40,667
New +$8.79M
BEPC icon
41
Brookfield Renewable
BEPC
$6.5B
$8.06M 0.85%
183,935
+12,179
+7% +$450K
AMGN icon
42
Amgen
AMGN
$225B
$8.01M 0.84%
33,130
-1,382
-4% -$318K
ELV icon
43
Elevance Health
ELV
$86.6B
$7.99M 0.84%
16,270
-136
-0.8% -$62.2K
RGLD icon
44
Royal Gold
RGLD
$19.7B
$7.47M 0.79%
52,900
-32,800
-38% -$3.83M
MRK icon
45
Merck
MRK
$328B
$7.17M 0.75%
87,435
-826
-0.9% -$65.1K
IMAX icon
46
IMAX
IMAX
$2.81B
$7.11M 0.75%
375,693
-5,639
-1% -$106K
SNA icon
47
Snap-on
SNA
$21.1B
$7.07M 0.74%
34,413
-435
-1% -$91.8K
MSI icon
48
Motorola Solutions
MSI
$77.7B
$6.86M 0.72%
28,331
-3,837
-12% -$892K
FISV
49
Fiserv Inc
FISV
$27.4B
$6.72M 0.71%
66,283
-200
-0.3% -$20.2K
ILMN icon
50
Illumina
ILMN
$29.1B
$6.7M 0.71%
19,725
-4
-0% -$1.35K

Similar funds

Alpine Woods Capital Investors's Q1 2022 Portfolio in Review

As of Q1 2022, Alpine Woods Capital Investors held 228 positions worth $950M, down 6.2% from $1.01B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Alpine Woods Capital Investors's Q1 2022 filing shows 18 new, 38 increased, 95 reduced and 16 closed positions. Its largest new stake was Adobe: 20,658 shares worth $9.41M. The largest sale was Apple, an estimated $13.5M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Alpine Woods Capital Investors's largest Q1 2022 buy was Adobe: 20,658 shares worth $9.41M.
  • Alpine Woods Capital Investors added most to Quest Diagnostics in Q1 2022, an estimated $9.2M increase.
  • Alpine Woods Capital Investors's biggest Q1 2022 reduction was Apple, cutting an estimated $13.5M.
  • Alpine Woods Capital Investors fully exited CyrusOne Inc Common Stock in Q1 2022, selling an estimated $8.96M.
  • Alpine Woods Capital Investors's ten largest holdings make up 22% of its $950M portfolio in Q1 2022.
  • Alpine Woods Capital Investors opened 18 new positions and closed 16 in Q1 2022.
  • Alpine Woods Capital Investors's portfolio value fell 6.2% quarter-over-quarter to $950M.

Based on Alpine Woods Capital Investors's 13F filing for Q1 2022, filed 10 May 2022.